Kintor Pharmaceutical Limited (HKG:9939)
Hong Kong · Delayed Price · Currency is HKD 2.210
-0.110 (-4.74%)
May 28, 2026, 4:08 PM HKT
Kintor Pharmaceutical Market Cap
Kintor Pharmaceutical has a market cap or net worth of 1.09 billion as of May 28, 2026. Its market cap has increased by 94.73% in one year.
Market Cap
1.09B
Enterprise Value
1.15B
Revenue
36.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.21
Market Cap Chart
Since May 22, 2020, Kintor Pharmaceutical's market cap has decreased from 7.94B to 1.09B, a decrease of -86.27%. That is a compound annual growth rate of -28.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 1.14B | 18.37% |
| Dec 31, 2025 | 967.31M | 130.32% |
| Dec 31, 2024 | 419.98M | -42.42% |
| Dec 29, 2023 | 729.42M | -83.45% |
| Dec 30, 2022 | 4.41B | -7.54% |
| Dec 31, 2021 | 4.77B | 23.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mabpharm | 1.75B |
| Frontage Holdings | 1.66B |
| Beijing Biostar Pharmaceuticals | 1.53B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.49B |
| Cutia Therapeutics | 1.45B |
| Zhaoke Ophthalmology | 1.40B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.40B |
| CANbridge Pharmaceuticals | 1.06B |